Abstract：
The Prior Authorization Task Force of the American Academy of Allergy, Asthma & Immunology (AAAAI), a presidential initiative of David Khan, MD, FAAAI, was established to develop an AAAAI position statement outlining ways to improve health care for our patients, to support legislation that advocates for prior authorization (PA) reform and identify the impact PA has on its membership using a questionnaire survey. This article describes the results of this survey. An electronic anonymous survey questionnaire was developed to assess the impact and burden of PA on AAAAI members and their staff and patients. Surveys were sent to randomly selected members and fellows of the AAAAI in the United States. Descriptive statistics were used to analyze the results by the Information Services team of the AAAAI and the authors of this work group report. The questionnaire responses from allergy immunology specialists demographically reflected the AAAAI membership and indicate that PAs can significantly affect patient care delivery and increase administrative burden to clinical practices, leading to serious adverse events in some circumstances. Differential responses regarding PAs for various medication classes likely reflect the physician\'s patient population, which can shift prescribing patterns. Prior authorization is a serious health care problem that is wasting financial resources and needlessly placing patients in danger when they are unable to access medications or medical services required for clinical management. The results of this questionnaire study support the recommendations made in the recent AAAAI position statement on PA.
摘要：
美国过敏学会事先授权工作组，哮喘和免疫学（AAAAI），大卫·汗的总统倡议，MD,FAAAI,旨在制定AAAAI立场声明，概述改善患者医疗保健的方法，支持倡导事先授权（PA）改革的立法，并通过问卷调查确定PA对其成员的影响。本文介绍了本次调查的结果。开发了电子匿名调查问卷，以评估PA对AAAAI成员及其工作人员和患者的影响和负担。调查已发送给美国AAAAI的随机选择的成员和研究员。AAAAI的信息服务团队和该工作组报告的作者使用描述性统计数据来分析结果。过敏免疫学专家的问卷答复在人口统计上反映了AAAAI成员资格，并表明PA可以显着影响患者的护理交付并增加临床实践的行政负担。在某些情况下导致严重不良事件。关于不同药物类别的PA的差异反应可能反映了医生的患者群体，可以改变处方模式。事先授权是一个严重的医疗保健问题，浪费了财政资源，并且在患者无法获得临床管理所需的药物或医疗服务时不必要地将患者置于危险之中。这项问卷调查研究的结果支持最近的AAAAI关于PA的立场声明中提出的建议。
